Medisys
Tick-Borne Encephalitis Vaccination in
Canada
Tick Borne Encephalitis
Description
TBE (Tick-Borne Encephalitis)
is a viral disease transmitted by ticks.
The virus attacks the nervous system
and can result in long-term neurological
symptoms and even death. TBE can cause
both mild and severe illnesses, with
permanent consequences such as disorders
of the autonomic nervous system, concentration
problems, paralysis and depression.
A confirmed case of TBE
is defined as a febrile patient with
clinical signs/ symptoms of meningitis
or meningoencephalitis, mild to moderate
elevation of cell counts in CSF, and
the presence of serum IgM and/or IgG
antibodies against TBE virus. A recent
stay in a TBE-endemic area or facultative
history of tick bite can assist with
identifying a TBE patient. The actual
diagnosis of TBE must be established
in the laboratory.
Methods of Transmission
TBE is transmitted through bites from
infected ticks. The Ixodes ricinus tick
(commonly referred to as the castor-bean
tick) is prevalent across Europe. Not
every tick transmits the dangerous
TBE virus, but the rate of infestation
in some elevated-risk areas can be
high. Those who engage in outdoor recreation
sports such as hiking, biking and camping
are at elevated risk. The following
countries have been identified as TBE-endemic
regions:
Symptoms
The typical clinical picture of TBE is characterized by a biphasic course with
non-specific influenza-like symptoms, followed by an asymptomatic interval
and a second stage of the disease with at least four clinical manifestations
of different severity: meningitis, meningoencephalitis, meningoencephalomyelitis,
meningoradiculoneuritis. Patients may experience just one of the phases. Up
to 46% of patients are left with permanent sequelae and need many years of
treatment and rehabilitation.
Prevention
TBE is easily prevented by vaccination.
FSME-IMMUN is the only registered TBE
vaccine in Canada. Over 100 million
doses of FSME-IMMUN have been administered
worldwide. Travellers to TBE-endemic
regions are advised to receive the
TBE vaccination.
Treatment
There
is no therapy for TBE. Since there is
no specific treatment targeting the TBE
virus, symptomatic treatment of patients
with TBE is required. Strict bed rest for
10 days is imperative
Duration of Immunity
There is a protection rate of above 90%
after the second vaccination and above
97% after completion of the primary
vaccination schedule (3 doses). The
seropositivity rates as determined
by ELISA and NT three years after the
third vaccination were 87.7% and 94.2%
respectively.
Montreal
Tick-Borne Encephalitis Vaccine
500 Sherbrooke Street West, 11th Floor
Montreal, Quebec H3A 3C6
Appointments: 514-499-2772
Quebec
City Tick-Borne Encephalitis Vaccine
3175, chemin des Quatre-Bourgeois, Suite
380
Québec, Québec G1W 2K7
Appointments: 418 681-0167
Toronto
Tick-Borne Encephalitis Vaccine
123 Edward Street, Suite 505
Toronto, Ontario M5G 1E2
Appointments: 416-730-5700
95 St. Clair Avenue West, 12th Floor
Toronto, Ontario M4V 1N6
Appointments: 416-926-2698
Guelph
Tick-Borne Encephalitis Vaccine
83 Dawson Road, Suite 101
Guelph, Ontario N1H 1B1
Appointments: 519-840-0106
Ottawa
Tick-Borne Encephalitis Vaccine
1545 Carling Ave, Suite 210
Ottawa, Ontario K1Z 8P9
Appointments: 613-521-8313
Calgary
Tick-Borne Encephalitis Vaccine
321 6th Ave SW - Suite 960
Calgary, Alberta T2P 3H3
Appointments: 403-232-6244
Vancouver
Tick-Borne Encephalitis Vaccine
1090 West Pender, 11th Floor
Vancouver, British Columbia V6E 2N7
Appointments: 604-681-2400
|